STOCK TITAN

BioCorRx New (BICX) Stock Price, News & Analysis

BICX OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
83 125 sessions, November 19, 2025 to November 19, 2026
Largest daily move
+95.7% close of December 19, 2025
1-year change
-27.6% closing prices, November 19, 2025 to November 19, 2026
1-month change
-19.6% closing prices, October 12, 2026 to November 19, 2026

Company Description

BioCorRx New (OTC: BICX) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $6.2M.

BICX has declined 27.6% over the past year. The last closing price was $0.2010.

For FY2025, BioCorRx New reported revenue of $797K with net income of -$3.4M and diluted earnings per share of -$0.19.

This page collects what Stock Titan holds for BICX, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.2010
-
-
Last updated: at
-27.6%
Performance 1 year
30.6M
Shares outstanding As of November 16, 2026.

BioCorRx New (BICX) closed at $0.2010 on November 19, 2026. Over the past 12 months, the price has lost 27.6%.

See what a $1,000 investment in BICX would be worth today

Average down calculator for BICX

BICX Metrics & Rankings

Price returns through November 19, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

BioCorRx New has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, fda approval, clinical trial. View all BICX news →

Financial Highlights

BioCorRx New generated $797K in revenue in FY2025, operating income reached -$4.8M, and net income was -$3.4M. Diluted earnings per share stood at -$0.19. The company generated -$2.3M in operating cash flow. The current ratio was 0.10, measuring current assets divided by current liabilities.

$797K
Revenue (FY2025)
-$3.4M
Net Income (FY2025)
-$2.3M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for BICX.

Short Interest History

Last 12 Months

Short interest in BioCorRx New (BICX) currently stands at 9.9 thousand shares, down 0.2% from the previous reporting period, representing 0.1% of the float. Since November 2025, short interest has increased by 82425.0%.

Days to Cover History

Last 12 Months

Days to cover for BioCorRx New (BICX) currently stands at 22.2 days, up 412.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 2120%. Across the settlements charted above, it has ranged from 1.0 to 127.8 days.

BICX Company Profile & Sector Positioning

BioCorRx New (BICX) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing BICX often look at related companies in the same sector, including Syra Health Corp (SYRA), Veltex Corp (VLXC), Xcelerate Inc (XCRT), Univec Inc (UNVC), and Numinus Wellness Inc (NUMIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BICX's relative position within its industry.

Frequently Asked Questions

The current stock price of BioCorRx New (BICX) is $0.2010 as of November 19, 2026.

The market cap of BioCorRx New (BICX) is approximately $6.2M. Learn more about what market capitalization means .

The FY2025 revenue of BioCorRx New (BICX) is $797K, from its most recent completed fiscal year.

The FY2025 net income of BioCorRx New (BICX) is -$3.4M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of BioCorRx New (BICX) is -$0.19 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of BioCorRx New (BICX) is -$2.3M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of BioCorRx New (BICX), current assets divided by current liabilities, was 0.10 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of BioCorRx New (BICX) is -$4.8M for FY2025, its most recent completed fiscal year. Learn about operating income.